Wells Fargo & Company Amarin Corp Plcuk Call Options Transaction History

Wells Fargo & Company

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 09, 2021	BUY	$4.04 - $5.31 $568,428 - $747,117	140,700 Added 121.92%	256,100 $21,000
Q3 2020 Nov 05, 2020	BUY	$3.64 - $7.76 $95,004 - $202,536	26,100 Added 29.23%	115,400 $5,000
Q1 2020 May 14, 2020	BUY	$4.0 - $21.53 $357,200 - $1.92 Million	89,300 New	89,300 $2,000

187

88.1M

528K

219K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $319M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.